Gastroenterology
Volume 87, Issue 1 , Pages 229-233 , July 1984

Gallstone dissolution and the cholesterol-bile acid-lipoprotein axis. Propitious effects of ursodeoxycholic acid

  • Hans Fromm

      Affiliations

    • Corresponding Author InformationAddress requests for reprints to: Hans Fromm, M.D., Gastroenterology Unit, Department of Medicine, Montefiore Hospital, 3459 Fifth Avenue, Pittsburgh, Pennsylvania 15213.
    • Gastroenterology Unit Montefiore Hospital Pittsburgh, Pennsylvania, USA
    • Department of Medicine University of Pittsburgh School of Medicine Pittsburgh, Pennsylvania, USA

References 

  1. Fromm H. Ursodeoxycholic acid for gallstone dissolution: the emergence of a new therapeutic application for an old bile acid. In:  Fisher MM,  Goresky CA,  Shaffer EA,  Strasberg SM editor. Gallstones. New York: Plenum; 1979;p. 363–370
  2. Bachrach WH, Hofmann AF. Ursodeoxycholic acid in the treatment of cholesterol cholelithiasis. Dig Dis Sci. 1982;27:737–856
  3. Salen G, Tint GS, Eliav B, Deering N, Mosbach EH. Increased formation of ursodeoxycholic acid in patients treated with chenodeoxycholic acid. J Clin Invest. 1974;53:612–621
  4. Makino I, Shinozaki K, Yoshino K, Nakagawa S. Dissolution of cholesterol gallstones by ursodeoxycholic acid. Jpn J Gastroenterol. 1975;72:690–702
  5. Tint GS, Salen G, Colalillo A, et al.  Ursodeoxycholic acid: a safe and effective agent for dissolving gallstones. Ann Intern Med. 1982;97:351–356
  6. Roda E, Bazzoli F, Labate AMM, et al.  Ursodeoxycholic acid vs chenodeoxycholic acid as cholesterol gallstone-dissolving agents: a comparative randomized study. Hepatology. 1982;2:804–810
  7. Fromm H, Roat JW, Gonzalez V, Sarva RP, Farivar S. Comparative efficacy and side effects of ursodeoxycholic and chenodeoxycholic acids in dissolving gallstones. A double-blind controlled study. Gastroenterology. 1983;85:1257–1264
  8. Fromm H, Sarva RP, Bazzoli F, Ceryak S, Mendelow L. Formation of ursodeoxycholic acid from chenodeoxycholic acid in the human colon: studies of the role of 7-ketolithocholic acid as an intermediate. J Lipid Res. 1983;24:841–853
  9. Fromm H, Carlson GL, Hofmann AF, Farivar S, Amin P. Metabolism in man of 7-ketolithocholic acid: precursor of cheno- and ursodeoxycholic acids. Am J Physiol. 1980;239:G161–G166
  10. Fedorowski T, Salen G, Zaki FG, Shefer S, Mosbach EH. Comparative effects of ursodeoxycholic acid and chenodeoxycholic acid in the rhesus monkey. Biochemical and ultra-structural studies. Gastroenterology. 1978;74:75–81
  11. Sarva RP, Fromm H, Farivar S, et al.  Comparison of the effects between ursodeoxycholic and chenodeoxycholic acids on liver function and structure and on bile acid composition in the rhesus monkey. Gastroenterology. 1980;79:629–636
  12. Miyai K, Javitt NB, Gochman N, Jones HM, Baker D. Hepatotoxicity of bile acids in rabbits. Ursodeoxycholic acid is less toxic than chenodeoxycholic acid. Lab Invest. 1982;46:428–437
  13. Fromm H, Erbler HC, Eschler A, Schmidt FW. Alterations of bile acid metabolism during treatment with chenodeoxycholic acid. Studies of the role of the appearance of ursodeoxycholic acid in the dissolution of gallstones. Klin Wschr. 1976;54:1125–1131
  14. Schoenfield LJ, Lachin JM  The Steering Committee and The National Cooperative Gallstone Study Group. Chenodiol (chenodeoxycholic acid) for dissolution of gallstones: the National Cooperative Gallstone Study. Ann Intern Med. 1981;95:257–282
  15. Hardison WGM, Grundy SM. The effect of ursodeoxycholate and its taurine conjugate on bile acid synthesis and cholesterol absorption. Gastroenterology. 1984;87:130–135
  16. von Bergmann K, Epple-Gutsfeld M, Leiss O. Differences in the effects of chenodeoxycholic and ursodeoxycholic acids on biliary lipid secretion and bile acid synthesis in patients with gallstones. Gastroenterology. 1984;87:136–143
  17. Nilsell K, Angelin B, Leijd B, Einarsson K. Comparative effects of ursodeoxycholic acid and chenodeoxycholic acid on bile acid kinetics and biliary lipid secretion in man. Evidence for different modes of action on bile acid synthesis. Gastroenterology. 1983;85:1248–1256
  18. Corrigan OI, Su CC, Higuchi WI, Hofmann AF. Mesophase formation during cholesterol dissolution in ursodeoxycholate-lecithin solutions: new mechanism for gallstone dissolution in humans. J Pharm Sci. 1980;69:869–870
  19. Salvioli G, Igimi H, Carey MC. Cholesterol gallstone dissolution in bile. Dissolution kinetics of crystalline cholesterol monohydrate by conjugated chenodeoxycholate-lecithin and conjugated ursodeoxycholate-lecithin mixtures: dissimilar phase equilibria and dissolution mechanisms. J Lipid Res. 1983;24:701–720
  20. Park Y-H, Igimi H, Carey MC. Dissolution of human cholesterol gallstones in simulated chenodeoxycholate-rich and ursodeoxycholate-rich biles. An in vitro study of dissolution rates and mechanisms. Gastroenterology. 1984;87:150–158
  21. Leiss O, von Bergmann K, Streicher U, Strotkoetter H. Effect of three different dihydroxy bile acids on intestinal cholesterol absorption in normal volunteers. Gastroenterology. 1984;87:144–149
  22. Ponz de Leon M, Carulli N, Loria P, Iori R, Zironi F. Cholesterol absorption during bile acid feeding. The effect of ursodeoxycholic (UDCA) administration. Gastroenterology. 1980;78:214–219
  23. Sama C, LaRusso NF, Lopez del Pino V, Thistle JL. Effects of acute bile acid administration on biliary lipid secretion in healthy volunteers. Gastroenterology. 1982;82:515–525
  24. Schwartz CC, Berman M, Vlahcevic ZR, Halloran LG, Gregory DM, Swell L. Multicompartmental analysis of cholesterol metabolism in man. J Clin Invest. 1978;61:408–423
  25. Long TT, Jakoi L, Stevens R, Quarfordt S. The sources of rat biliary cholesterol and bile acid. J Lipid Res. 1978;19:872–878
  26. Turley SD, Spady DK, Dietschy JM. Alteration of the degree of biliary cholesterol saturation in the hamster and rat by manipulation of the pools of preformed and newly synthesized cholesterol. Gastroenterology. 1983;84:253–264
  27. Sabesin SM. Cholestatic lipoproteins—their pathogenesis and significance (editorial). Gastroenterology. 1982;83:704–709
  28. Angelin B, Ewerth S, Einarsson K. Ursodeoxycholic acid treatment in cholesterol gallstone disease: effects on hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase activity, biliary lipid composition, and plasma lipid levels. J Lipid Res. 1983;24:461–468
  29. Hamprecht B, Roscher R, Waltinger G, Nussler C. The influence of bile acids on the activity of rat liver HMG-CoA reductase. II. Effect of cholic acid on lymph fistula rats. Eur J Biochem. 1971;18:15–19
  30. Maton P, Ellis HJ, Higgins MJP, Dowling RH. Hepatic HMG-CoA reductase in human cholelithiasis: effects of chenodeoxycholic and ursodeoxycholic acids. Eur J Clin Invest. 1980;10:325–332
  31. Salen G, Colalillo A, Verga D, Bagan E, Tint GS, Shefer S. Effect of high and low doses of ursodeoxycholic acid on gallstone dissolution in humans. Gastroenterology. 1980;78:1412–1418
  32. Carulli N, Ponz de Leon M, Zironi F, et al.  Hepatic cholesterol and bile acid metabolism in subjects with gallstones: comparative effects of short term feeding of chenodeoxycholic and ursodeoxycholic acid. J Lipid Res. 1980;21:35–43
  33. Salvioli G, Carey MC. A novel in vitro perfusion system to study membrane dissolution by bile salts: different effects of taurochenodeoxycholate (TCDC) and tauroursodeoxycholate (TUDC) on lipid secretion and membrane resistance (abstr). Gastroenterology. 1982;82:1168
  34. Armstrong MJ, Carey MC. The hydrophobic-hydrophilic balance of bile salts. Inverse correlation between reverse-phase high performance liquid Chromatographic mobilities and micellar cholesterol-solubilizing capacities. J Lipid Res. 1982;23:70–80
  35. McJunkin B, Fromm H, Sarva RP, Amin P. Factors in the mechanism of diarrhea in bile acid malabsorption: fecal pH—a key determinant. Gastroenterology. 1981;80:1454–1464
  36. Fedorowski T, Salen G, Tint GS, Mosbach EH. Transformation of chenodeoxycholic acid and ursodeoxycholic acid by human intestinal bacteria. Gastroenterology. 1979;77:1068–1073
  37. Bazzoli F, Fromm H, Sarva RP, Sembrat RF, Ceryak S. Comparative formation of lithocholic acid from chenodeoxycholic and ursodeoxycholic acids in the colon. Gastroenterology. 1982;83:753–760
  38. Kimura T, Shimamura M, Yamaguchi A, Katayama T, Kurita T, Tanaka A. Solubilization of cultured cell membrane by bile acids. Acta Hepatol Jpn. 1981;2:1–7
  39. Nemchausky BA, Layden TJ, Boyer JL. Effects of chronic choleretic infusions of bile acids on the membrane of the bile canaliculus. A biochemical and morphologic study. Lab Invest. 1977;36:259–267
  40. Davis RA, Kern F, Showalter R, Sutherland E, Sinensky M, Simon FR. Alterations of hepatic Na+,K+-ATPase and bile flow by estrogen: effects on liver surface membrane lipid structure and function. In: Proc Natl Acad Sci USA. 75:1978;p. 4130–4134
  41. Keeffe EB, Scharschmidt BF, Blankenship NM, Ockner RK. Studies of the relationships among bile flow, liver plasma membrane NaK-ATPase, and membrane microviscosity in the rat. J Clin Invest. 1979;64:1590–1598
  42. Thistle JL, LaRusso NF, Hofmann AF, Turcotte J, Carlson GL, Ott BJ. Differing effects of ursodeoxycholic or chenodeoxycholic acid on biliary cholesterol saturation and bile acid metabolism in man. A dose response study. Dig Dis Sci. 1982;27:161–168
  43. Albers JJ, Grundy SM, Cleary PA, Small DM, Lachin JM, Schoenfield LJ. National Cooperative Gallstone Study: the effect of chenodeoxycholic acid on lipoproteins and apolipoproteins. Gastroenterology. 1982;82:638–646
  44. Kesaniemi YA, Witztum JL, Steinbrecher UP. Receptor-mediated catabolism of low density lipoprotein in man. J Clin Invest. 1983;71:950–959
  45. Shepherd J, Packard CJ, Bicker S, Lawrie TDV, Morgan HG. Cholestyramine promotes receptor-mediated low density lipoprotein catabolism. N Engl J Med. 1980;302:1219–1222

PII: 0016-5085(84)90152-5

Gastroenterology
Volume 87, Issue 1 , Pages 229-233 , July 1984

Article Tools